GSK Sues Pfizer, BioNTech for Share of Billions in Vaccine Sales

GlaxoSmithKline filed a federal lawsuit seeking to recoup a share of the tens of billions of dollars in revenue Pfizer and BioNTech have reported from sales of their Covid-19 vaccines, which GSK ... Read More

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of the COVID-19 ... Read More

Pfizer jumps as investors look past Covid vaccine forecast to possible price hikes

Vaccine rival Moderna (MRNA) also said its sees "improved visibility" in its Covid sales ... our business in future periods, helping us to further invest in activities that drive Pfizer ... Read More

After COVID excess, Pfizer bracing for a hangover in 2023

Pfizer reaped the rewards of its COVID-19 vaccines ... in pandemic sales has also returned investors' attention to Pfizer's ability to generate growth in other areas of its business, as big ... Read More

Vaccine sales plunge for Sanofi in fourth quarter

In the fourth quarter, polio/pertussis/hib (PPH) vaccines sales decreased 16.9% to €443 million, reflecting lower sales in the rest of the world. In addition, PENTAXIM sales in China decreased ... Read More

Pfizer’s plot to win the RSV vaccine race

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here with an update on the biotech market, a ... Read More

Lawsuit Alleges Pfizer Deceived and Censored Americans Over COVID Vaccine

Texas Attorney General Ken Paxton filed a lawsuit against Pfizer ... negatively impact sales. “Pfizer intentionally misrepresented the efficacy of its COVID-19 vaccine and censored persons ... Read More

pfizer inc.

Pfizer, Inc. on Wednesday forecast 2024 sales that could be as much as $5 billion below Wall Street expectations, driving shares down 9% to a 10-year low. Pfizer CEO Albert Bourla criticized the ... Read More

Pfizer Reports Positive Results From Phase 3 Abrysvo Vaccine Study

(RTTNews) - Tuesday, Pfizer Inc. (PFE) revealed positive immunogenicity and safety results from the ongoing pivotal Phase 3 clinical trial of Abrysvo vaccine. The MONeT trial assessed the ... Read More

Pfizer to seek approval for RSV vaccine for people as young as 18

(CNN) — An RSV vaccine already used for older adults could help protect people as young as 18 who are at increased risk of the disease, drugmaker Pfizer said in a news release Tuesday. Read More